1. Home
  2. GRWG vs ACET Comparison

GRWG vs ACET Comparison

Compare GRWG & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

HOLD

Current Price

$1.28

Market Cap

89.2M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.46

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRWG
ACET
Founded
2008
1947
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.2M
77.3M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
GRWG
ACET
Price
$1.28
$8.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$2.50
$48.33
AVG Volume (30 Days)
645.9K
137.9K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
51.22
N/A
EPS
N/A
N/A
Revenue
$193,365,479.00
N/A
Revenue This Year
$5.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
142.51
N/A
52 Week Low
$0.93
$0.46
52 Week High
$2.40
$9.05

Technical Indicators

Market Signals
Indicator
GRWG
ACET
Relative Strength Index (RSI) 56.58 61.66
Support Level $1.02 $6.28
Resistance Level $1.61 $8.46
Average True Range (ATR) 0.09 0.51
MACD 0.01 0.03
Stochastic Oscillator 42.31 82.18

Price Performance

Historical Comparison
GRWG
ACET

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: